Sulforaphane: The Master Nrf2 Activator

Sulforaphane is an isothiocyanate concentrated in broccoli — and most of all in young broccoli sprouts — that is the most potent natural activator of Nrf2, the transcription factor that switches on the body's own family of cytoprotective and antioxidant enzymes. Unlike vitamin C or vitamin E, which are consumed one-for-one as they neutralize a single radical, sulforaphane is an indirect antioxidant: a single dose triggers the synthesis of glutathione, NQO1, heme oxygenase-1, and dozens of other defensive proteins whose effect lasts for days. This catalytic, self-amplifying mechanism is why sulforaphane has been the focus of more than two decades of chemoprevention research at Johns Hopkins (Talalay, Fahey, Kensler) and a growing list of clinical trials spanning detoxification, cancer prevention, autism, cardiometabolic health, and Helicobacter pylori infection.


Table of Contents

  1. What Sulforaphane Is
  2. Why Broccoli Sprouts Are the Richest Source
  3. The Nrf2/ARE Mechanism: Indirect Antioxidant Defense
  4. Direct Scavengers vs Catalytic Enzyme Induction
  5. Maximizing Sulforaphane Yield
  6. Detoxification & Phase II Enzymes
  7. Cancer Chemoprevention Research
  8. Brain, Autism & Neuroprotection Research
  9. Cardiometabolic & Blood Sugar
  10. Helicobacter pylori & the Gut
  11. Forms & Dosing
  12. Cautions and Contraindications
  13. Key Research Papers
  14. Connections

What Sulforaphane Is

Sulforaphane (chemical name 1-isothiocyanato-4-(methylsulfinyl)butane) is a sulfur-containing compound in the isothiocyanate family. It does not exist pre-formed in significant amounts in intact plant tissue. Instead, cruciferous vegetables store an inert, water-soluble precursor called glucoraphanin (a glucosinolate) in one cellular compartment, and a hydrolytic enzyme called myrosinase in a separate compartment. The two are kept apart like the components of a chemical cold pack.

When the plant tissue is damaged — by an insect, by chopping, or by chewing — the compartments break open, myrosinase contacts glucoraphanin, and the enzyme cleaves the sugar group. The unstable product spontaneously rearranges into sulforaphane. In the intact plant this reaction is a defense mechanism: the pungent, slightly bitter isothiocyanate deters herbivores. In humans it is the step that converts a tasteless storage molecule into a bioactive Nrf2 inducer.

This two-part design has an important practical consequence. The amount of sulforaphane you actually absorb depends not on how much glucoraphanin a food contains, but on how much active myrosinase survives to convert it. Cooking, processing, freezing, and stomach acid can all destroy myrosinase, leaving the glucoraphanin to pass through largely unconverted. Understanding this is the difference between getting a meaningful dose and getting almost none.

Sulforaphane belongs to the same broad chemical family as the other cruciferous bioactives — indole-3-carbinol and diindolylmethane (DIM) derive from a different glucosinolate (glucobrassicin), while phenethyl isothiocyanate comes from watercress. Sulforaphane is the most studied of the group specifically because of its exceptional potency at activating Nrf2.

Back to Table of Contents


Why Broccoli Sprouts Are the Richest Source

All cruciferous vegetables — broccoli, cauliflower, cabbage, kale, Brussels sprouts, bok choy, arugula, radish, watercress — contain glucosinolates. But the concentration of glucoraphanin specifically (the sulforaphane precursor) varies enormously, and the single richest readily available source is the 3-day-old broccoli sprout.

The landmark observation came from Paul Talalay's laboratory at Johns Hopkins in 1997. Fahey, Zhang, and Talalay reported that 3-day-old broccoli sprouts contained 10 to 100 times more glucoraphanin by weight than the corresponding mature broccoli head. A small handful of sprouts could therefore deliver as much sulforaphane potential as a much larger serving of cooked broccoli. The young sprout front-loads its chemical defenses before it has physical defenses, which is why the precursor is so concentrated at that stage and then dilutes as the plant grows.

Relative glucoraphanin content, roughly highest to lowest:

Broccoli sprouts can be grown at home in a jar in 3-4 days from broccoli seed, which is why they are a favorite of the do-it-yourself longevity community. The relevant nutrient is concentrated, cheap, and renewable. The trade-off is food-safety vigilance: like any raw sprout grown in warm, humid conditions, broccoli sprouts can harbor bacteria if seeds are contaminated, so reputable seed sources and clean technique matter.

Broccoli sprouts and mature broccoli are covered in more depth on the Broccoli food page, which sits alongside this article as the dietary source for everything described here.

Back to Table of Contents


The Nrf2/ARE Mechanism: Indirect Antioxidant Defense

To understand why sulforaphane is special, you have to understand Nrf2 (nuclear factor erythroid 2-related factor 2). Nrf2 is a transcription factor — a master switch — that controls the expression of roughly 200 genes, many of them coding for the body's own antioxidant and detoxification enzymes. Think of Nrf2 as the foreman who, when summoned, opens the doors to the cell's entire defensive armory.

Under normal, unstressed conditions Nrf2 is held captive in the cytoplasm by a partner protein called Keap1 (Kelch-like ECH-associated protein 1). Keap1 continually grabs Nrf2 and tags it for destruction, keeping the foreman locked in a closet so the armory stays shut. Keap1 is studded with highly reactive cysteine sulfur atoms that act as sensors.

Sulforaphane is an electrophile with a strong affinity for exactly those reactive cysteines. When sulforaphane reacts with Keap1's sensor cysteines, it changes Keap1's shape so it can no longer tag Nrf2 for destruction. Newly made Nrf2 escapes, accumulates, travels into the nucleus, binds to a DNA sequence called the Antioxidant Response Element (ARE) in the promoters of its target genes, and switches them on. The armory doors swing open.

The genes that get switched on include the cell's heavy machinery of self-defense:

The result is that one sulforaphane molecule does not neutralize one radical. It flips a switch that causes the cell to manufacture thousands of enzyme molecules, each of which then neutralizes radicals or detoxifies carcinogens over and over for as long as the enzyme persists. This is why the effect of a single dose lasts for days — long after the sulforaphane itself has been cleared from the body.

Back to Table of Contents


Direct Scavengers vs Catalytic Enzyme Induction

This is the conceptual heart of why sulforaphane occupies a different category from most "antioxidants." It is worth drawing the contrast explicitly.

A direct antioxidant — vitamin C, vitamin E, beta-carotene, most polyphenols — works stoichiometrically. One molecule of vitamin C donates an electron to one free radical and is itself oxidized in the process. To keep neutralizing radicals you must keep supplying the antioxidant, and the molecule is used up. The protection lasts only as long as the antioxidant is present and is limited by how much you can absorb at one time. Direct antioxidants are fast but transient and self-limiting.

An indirect antioxidant — sulforaphane is the textbook example — works catalytically. It is not consumed neutralizing radicals; instead it triggers the cell to build enzymes that do the neutralizing. Those enzymes are catalysts, so each one processes a vast number of substrate molecules without being used up. And because the enzymes are proteins with a half-life of hours to days, the protective effect is sustained and self-amplifying long after the trigger is gone. Indirect induction is slower to start but far more durable and far-reaching.

Talalay's group coined the framing of sulforaphane as an inducer that turns on the body's own "cellular defenses" rather than a sacrificial scavenger. The practical implications:

This places sulforaphane alongside other Nrf2-relevant compounds such as curcumin, quercetin, and the precursor strategy of NAC — though sulforaphane is the most potent pure Nrf2 activator of the dietary group.

Back to Table of Contents


Maximizing Sulforaphane Yield

Because sulforaphane only forms when myrosinase meets glucoraphanin, how you prepare and eat the food determines how much you actually get. This is one of the most practically important and least-known aspects of the topic.

Chew thoroughly, or chop and wait

Chewing is what ruptures the plant cells and brings myrosinase and glucoraphanin together. Bolting food down whole leaves much of the glucoraphanin unconverted. If you chop raw broccoli and let it sit for several minutes before cooking or eating, the enzyme has time to do its work before heat can destroy it — the same "chop and hold" trick used to maximize allicin from garlic.

Heat destroys myrosinase — but there is a workaround

Myrosinase is heat-sensitive and is largely inactivated by boiling or prolonged high-heat cooking. Heavily cooked broccoli still contains glucoraphanin, but with no active enzyme to convert it, sulforaphane yield collapses. Two strategies recover most of the loss:

Sprouts as the highest-yield option

Raw broccoli sprouts carry both their own concentrated glucoraphanin and their own intact myrosinase, so they are the most reliable whole-food source. Eating them raw — in a salad, on a sandwich, or blended — preserves the enzyme. Gently blending or chopping them and letting the slurry rest a few minutes before eating maximizes conversion.

The gut microbiome as a backup converter

Even when no plant myrosinase survives, gut bacteria possess myrosinase-like activity and can convert some glucoraphanin to sulforaphane in the colon. This rescue is real but inefficient and highly variable between individuals — absorption from cooked-only broccoli may be only 10-20% of that from a preparation with active plant myrosinase. So microbiome conversion is a fallback, not a substitute for getting the food chemistry right.

Back to Table of Contents


Detoxification & Phase II Enzymes

The body clears fat-soluble toxins, environmental pollutants, and many drugs in two broad steps. Phase I (mostly cytochrome P450 enzymes) modifies the toxin, often making it temporarily more reactive. Phase II enzymes then conjugate that intermediate to a water-soluble handle (glutathione, glucuronic acid, sulfate) so it can be excreted in bile and urine. Sulforaphane is one of the most powerful known dietary inducers of phase II enzymes — precisely the enzymes (GSTs, NQO1, UGTs) that finish the job and carry toxins out of the body.

The most striking human evidence comes from a large randomized trial in Qidong, China, a region with heavy dietary exposure to aflatoxin (a potent liver carcinogen from mold) and airborne benzene and other pollutants. In a 2014 study led by the Johns Hopkins and Chinese teams (Egner, Kensler, and colleagues), nearly 300 adults drank a broccoli-sprout beverage standardized for glucoraphanin or placebo. The sulforaphane group showed significantly increased urinary excretion of detoxified conjugates of benzene and acrolein — direct human evidence that sulforaphane accelerates the elimination of common airborne pollutants by inducing the body's own conjugation enzymes.

Because the mechanism is enzyme induction rather than direct binding, sulforaphane upregulates a general-purpose detox program that applies to a wide range of substrates rather than one specific toxin. This is the rationale for its inclusion in many functional-medicine detoxification protocols and liver-support regimens, where it is paired with glutathione precursors and the cofactors phase II enzymes require.

Back to Table of Contents


Cancer Chemoprevention Research

Sulforaphane was first identified in 1992 by Zhang, Talalay, Cho, and Posner at Johns Hopkins precisely because they were hunting through broccoli extracts for the most potent inducer of the anticarcinogenic phase II enzyme NQO1. Cancer chemoprevention has been the central thread of sulforaphane research ever since, and it operates through several complementary mechanisms.

Epidemiologically, high cruciferous-vegetable intake has been associated with reduced risk of several cancers in observational cohorts, though confounding makes diet-cancer epidemiology difficult to interpret cleanly. The strongest human interventional signals to date are biomarker and early-disease studies rather than hard cancer-incidence endpoints:

The honest summary: sulforaphane has a deep, decades-long mechanistic and animal evidence base for chemoprevention, supportive epidemiology, and encouraging early human biomarker trials — but it is not a cancer treatment, and definitive randomized incidence trials are still lacking. It is best framed as a dietary chemopreventive strategy, not a therapy. See the Cancer overview and the broader Oncology section for context.

Back to Table of Contents


Brain, Autism & Neuroprotection Research

The brain is exquisitely vulnerable to oxidative stress and neuroinflammation, and Nrf2 activation is neuroprotective in numerous animal models. Sulforaphane crosses the blood-brain barrier, which makes it one of the more interesting dietary Nrf2 activators for neurological research.

The most widely cited human study is a 2014 randomized, placebo-controlled trial led by Kanwaljit Singh and Andrew Zimmerman (published in PNAS) in young men with moderate-to-severe autism spectrum disorder. Participants received a sulforaphane-rich broccoli-sprout extract or placebo for 18 weeks. The sulforaphane group showed statistically significant improvements in standardized measures of social interaction, aberrant behavior, and verbal communication, with scores tending to revert toward baseline after the supplement was stopped. The proposed rationale connects to the "fever effect" sometimes reported in autism — the heat-shock and Nrf2 stress-response pathways that sulforaphane activates overlap with the pathways transiently engaged during fever, and the trial was designed to test whether chronically engaging them would reproduce the behavioral improvement. Subsequent trials have produced mixed but generally cautiously positive results, and this remains an active and important area of investigation rather than settled practice. The autism condition page lives at Autism.

Beyond autism, preclinical and early clinical work has explored sulforaphane for:

These are research signals, not established treatments. But the combination of blood-brain-barrier penetration plus potent Nrf2 activation makes sulforaphane one of the most actively studied dietary compounds in neuroscience.

Back to Table of Contents


Cardiometabolic & Blood Sugar

Oxidative stress and low-grade inflammation are central to insulin resistance, type 2 diabetes, and vascular disease, so Nrf2 activation is a plausible cardiometabolic lever.

The most notable clinical result is a 2017 study published in Science Translational Medicine by Annika Axelsson and colleagues at Lund University. Combining cell, animal, and human data, the team identified sulforaphane (delivered as a concentrated broccoli-sprout extract) as a suppressor of hepatic glucose production. In a 12-week randomized trial in patients with type 2 diabetes, the broccoli-sprout-extract group — particularly obese participants with dysregulated disease — showed a meaningful reduction in fasting blood glucose and HbA1c compared with placebo. The proposed mechanism was downregulation of the liver enzymes that drive excess glucose output, mediated through Nrf2.

Additional cardiometabolic signals from human and animal work include modest improvements in blood pressure, reductions in markers of vascular inflammation and oxidized LDL, and improvements in markers of non-alcoholic fatty liver disease (see NAFLD). As with the other domains, these are promising adjunctive findings rather than replacements for established therapy.

Back to Table of Contents


Helicobacter pylori & the Gut

One of the most distinctive properties of sulforaphane is direct antibacterial activity against Helicobacter pylori, the stomach bacterium responsible for most peptic ulcers and a recognized risk factor for gastric cancer. This is notable because most of sulforaphane's effects are indirect (via Nrf2), but its action against H. pylori appears to be both direct bactericidal activity and Nrf2-mediated protection of the gastric lining.

Jed Fahey and Talalay's group showed in the early 2000s that sulforaphane inhibits and kills H. pylori in culture — including antibiotic-resistant strains — and eradicates the infection from the stomach tissue of infected mice, while also blocking benzo[a]pyrene-induced stomach tumors. A 2009 randomized human pilot study (Yanaka, Fahey, and colleagues) found that 8 weeks of daily broccoli-sprout consumption reduced markers of H. pylori colonization and gastric inflammation in infected patients, with the effect waning after sprouts were discontinued.

Sulforaphane is not a cure for H. pylori on its own and does not replace standard eradication antibiotics, but broccoli sprouts are a reasonable, evidence-supported adjunct for reducing bacterial burden and protecting the gastric mucosa. The relevant clinical context lives in the Gastroenterology section.

Back to Table of Contents


Forms & Dosing

Sulforaphane is delivered three main ways, each with trade-offs around potency, reliability, and convenience.

Practical guidance. If you want a food-first approach, eat raw or lightly steamed broccoli sprouts daily, or add raw mustard-seed powder to cooked broccoli to rescue conversion. If you choose a supplement, the single most important label question is whether active myrosinase is included or whether the product delivers preformed/stabilized sulforaphane — a high glucoraphanin number on a myrosinase-free capsule is largely wasted. Because Nrf2 induction is durable (days), once-daily dosing is sufficient; there is no need to spread it through the day the way you would a direct antioxidant.

Back to Table of Contents


Cautions and Contraindications

Broccoli sprouts and sulforaphane have an excellent safety record in clinical trials at the doses studied, but a few considerations apply.

Back to Table of Contents


Key Research Papers

Selected peer-reviewed studies on sulforaphane, with direct DOI or PubMed links. Authors are given as plain text; the linked element is the citation locator.

  1. Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proceedings of the National Academy of Sciences USA. 1992;89(6):2399–2403
  2. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proceedings of the National Academy of Sciences USA. 1997;94(19):10367–10372
  3. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al. (Talalay P). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences USA. 2002;99(18):11908–11913
  4. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Talalay P, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proceedings of the National Academy of Sciences USA. 2002;99(11):7610–7615
  5. Yanaka A, Fahey JW, Fukumoto A, et al. Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prevention Research. 2009;2(4):353–360
  6. Egner PA, Chen JG, Kensler TW, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prevention Research. 2014;7(8):813–823
  7. Singh K, Connors SL, Zimmerman AW, Fahey JW, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proceedings of the National Academy of Sciences USA. 2014;111(43):15550–15555
  8. Axelsson AS, Tubbs E, Mecham B, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Science Translational Medicine. 2017;9(394):eaah4477
  9. Cipolla BG, Mandron E, Lefort JM, et al. Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy. Cancer Prevention Research. 2015;8(8):712–719
  10. Clarke JD, Hsu A, Riedl K, Schwartz S, Williams DE, Dashwood RH, Ho E. Bioavailability and inter-conversion of sulforaphane and erucin in humans consuming broccoli sprouts or broccoli supplement. Pharmacological Research. 2011;64(5):456–463
  11. Okunade O, Niranjan K, Ghawi SK, Kuhnle G, Methven L. Supplementation of the diet by exogenous myrosinase via mustard seeds to increase the bioavailability of sulforaphane in healthy human subjects. Molecular Nutrition & Food Research. 2018;62(18):1700980
  12. Houghton CA, Fassett RG, Coombes JS. Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality? Oxidative Medicine and Cellular Longevity. 2016;2016:7857186

Live PubMed Searches

  1. PubMed: Sulforaphane and Nrf2
  2. PubMed: Sulforaphane broccoli sprouts
  3. PubMed: Sulforaphane cancer chemoprevention
  4. PubMed: Sulforaphane autism
  5. PubMed: Sulforaphane Helicobacter pylori
  6. PubMed: Sulforaphane type 2 diabetes
  7. PubMed: Glucoraphanin myrosinase bioavailability
  8. PubMed: Sulforaphane phase II detoxification

External Authoritative Resources

Back to Table of Contents


Connections

Back to Table of Contents